Scherer, P. E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537–1545 (2006).
Google Scholar
Chami, N. et al. Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities. Nat. Med. (2025).
Gagnon, E., Paulin, A., Mitchell, P. L. & Arsenault, B. J. Disentangling the impact of gluteofemoral versus visceral fat accumulation on cardiometabolic health using sex-stratified Mendelian randomization. Atherosclerosis 386, 117371 (2023).
Google Scholar
Ou, M. -Y., Zhang, H., Tan, P. -C., Zhou, S. -B. & Li, Q. -F. Adipose tissue aging: mechanisms and therapeutic implications. Cell Death Dis. 13, 300 (2022).
Google Scholar
Zhang, M., Hu, T., Zhang, S. & Zhou, L. Associations of different adipose tissue depots with insulin resistance: a systematic review and meta-analysis of observational studies. Sci. Rep. 5, 18495 (2015).
Google Scholar
Shen, F., Guo, C., Zhang, D., Liu, Y. & Zhang, P. Visceral adiposity index as a predictor of type 2 diabetes mellitus risk: a systematic review and dose–response meta-analysis. Nutr. Metab. Cardiovasc. Dis. 34, 811–822 (2024).
Google Scholar
Chiba, Y. et al. Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu Study. Hypertens. Res. 30, 229–236 (2007).
Google Scholar
Ruiz-Castell, M. et al. Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study. Sci. Rep. 11, 9121 (2021).
Google Scholar
Ismaiel, A., Jaaouani, A., Leucuta, D. -C., Popa, S. -L. & Dumitrascu, D. L. The visceral adiposity index in non-alcoholic fatty liver disease and liver fibrosis-systematic review and meta-analysis. Biomedicines 9, 1890 (2021).
Google Scholar
Xu, X. et al. Association of metabolic evaluation of visceral fat score with nonalcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES. Medicine 104, e42213 (2025).
Google Scholar
Ozato, N. et al. Association between visceral fat and brain structural changes or cognitive function. Brain Sci. 11, 1036 (2021).
Google Scholar
Silveira, E. A., Kliemann, N., Noll, M., Sarrafzadegan, N. & de Oliveira, C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes. Rev. 22, e13088 (2021).
Google Scholar
Usui, C. et al. Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. J. Nutr. Sci. Vitaminol. 56, 109–116 (2010).
Google Scholar
Zhang, X. et al. Association between MRI-based visceral adipose tissues and metabolic abnormality in a Chinese population: a cross-sectional study. Nutr. Metab. 19, 16 (2022).
Google Scholar
Liu, A. W. et al. Change in CT-measured abdominal subcutaneous and visceral but not thigh fat areas predict future insulin sensitivity. Diabetes Res. Clin. Pract. 154, 17–26 (2019).
Google Scholar
Zhu, K. et al. Longitudinal associations of DXA-measured visceral adipose tissue and cardiometabolic risk in middle-to-older aged adults. Nutr. Metab. Cardiovasc. Dis. 34, 2519–2527 (2024).
Google Scholar
Huffman, D. M. & Barzilai, N. Role of visceral adipose tissue in aging. Biochim. Biophys. Acta 1790, 1117–1123 (2009).
Google Scholar
Franczyk, M. P., He, M. & Yoshino, J. Removal of epididymal visceral adipose tissue prevents obesity-induced multi-organ insulin resistance in male mice. J. Endocr. Soc. 5, bvab024 (2021).
Google Scholar
García-Ruiz, I. et al. Omentectomy prevents metabolic syndrome by reducing appetite and body weight in a diet-induced obesity rat model. Sci. Rep. 8, 1540 (2018).
Google Scholar
Shin, J. A. et al. Visceral adipose tissue inflammation is associated with age-related brain changes and ischemic brain damage in aged mice. Brain. Behav. Immun. 50, 221–231 (2015).
Google Scholar
Barnhart, K. F. et al. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci. Transl. Med. 3, 108ra112 (2011).
Google Scholar
Lee, Y. et al. The effect of omentectomy added to bariatric surgery on metabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. Surg. Obes. Relat. Dis. 14, 1766–1782 (2018).
Google Scholar
Andersson, D. P. et al. Omentectomy in addition to gastric bypass surgery and influence on insulin sensitivity: a randomized double blind controlled trial. Clin. Nutr. 33, 991–996 (2014).
Google Scholar
Herrera, M. F. et al. Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial. Diabetes Care 33, 1413–1418 (2010).
Google Scholar
Fabbrini, E. et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 139, 448–455 (2010).
Google Scholar
Tchkonia, T. et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 17, 644–656 (2013).
Google Scholar
Neeland, I. J., Grundy, S. M., Li, X., Adams-Huet, B. & Vega, G. L. Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study. Nutr. Diabetes 6, e221 (2016).
Google Scholar
Ofenheimer, A. et al. Reference values of body composition parameters and visceral adipose tissue (VAT) by DXA in adults aged 18–81 years—results from the LEAD cohort. Eur. J. Clin. Nutr. 74, 1181–1191 (2020).
Google Scholar
Andrew, M. S. et al. Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons. Surg. Obes. Relat. Dis. 14, 833–841 (2018).
Google Scholar
Baskoy, G. et al. Mesenteric visceral lipectomy improves glucose tolerance in patients with type 2 diabetes: a pilot study. J. Clin. Endocrinol. Metab. (2024).
Gagnon, E. et al. Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases. Commun. Med. 2, 130 (2022).
Google Scholar
Liu, Y. & Liu, Q. Visceral adipose tissue had a causal, independent role in lowering the risk of Parkinson’s disease: a mendelian randomization study. Parkinsonism Relat. Disord. 92, 51–52 (2021).
Google Scholar
Porcheddu, T. et al. Causal association between visceral fat and coronary artery disease: a large-scale mendelian randomization analysis. Eur. Heart J. 45, ehae666.1544 (2024).
Google Scholar
Xu, F. -Q. et al. Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: a Mendelian randomization study. Int. J. Cancer 154, 530–537 (2024).
Google Scholar
Sun, X., Yuan, Y., Chen, L., Ye, M. & Zheng, L. Genetically predicted visceral adipose tissue and risk of nine non-tumour gastrointestinal diseases: evidence from a Mendelian randomization study. Int. J. Obes. 47, 406–412 (2023).
Google Scholar
Williams, R. & Periasamy, M. Genetic and environmental factors contributing to visceral adiposity in Asian populations. Endocrinol. Metab. 35, 681–695 (2020).
Google Scholar
Nazare, J. -A. et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity. Am. J. Clin. Nutr. 96, 714–726 (2012).
Google Scholar
Lemieux, S., Prud’homme, D., Bouchard, C., Tremblay, A. & Després, J. P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58, 463–467 (1993).
Google Scholar
Kammerlander, A. A. et al. Sex differences in the associations of visceral adipose tissue and cardiometabolic and cardiovascular disease risk: The Framingham Heart Study. J. Am. Heart Assoc. 10, e019968 (2021).
Google Scholar
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D. & Jensen, M. D. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113, 1582–1588 (2004).
Google Scholar
Malandrino, N. et al. Visceral fat does not contribute to metabolic disease in lipodystrophy. Obes. Sci. Pract. 5, 75–82 (2019).
Google Scholar
Vasandani, C., Li, X., Sekizkardes, H., Brown, R. J. & Garg, A. Phenotypic differences among familial partial lipodystrophy due to LMNA or PPARG variants. J. Endocr. Soc. 6, bvac155 (2022).
Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001).
Google Scholar
Rubino, F. et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13, 221–262 (2025).
Google Scholar
Nguyen, T. T. & Corvera, S. Adipose tissue as a linchpin of organismal ageing. Nat. Metab. 6, 793–807 (2024).
Google Scholar
Jayedi, A., Soltani, S., Zargar, M. S., Khan, T. A. & Shab-Bidar, S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ 370, m3324 (2020).
Google Scholar
Hinojosa-Gutiérrez, L. R., González-Sánchez, A. L., Rios-Muñoz, J. A., Aguilar-Guerrero, R. & Macías-Cervantes, H. E. Visceral fat as the main tomographic risk factor for COVID-19 mortality. Heart Lung 70, 191–196 (2025).
Google Scholar
Katzmarzyk, P. T., Mire, E. & Bouchard, C. Abdominal obesity and mortality: the Pennington Center Longitudinal Study. Nutr. Diabetes 2, e42 (2012).
Google Scholar
Koster, A. et al. Fat distribution and mortality: the AGES-Reykjavik Study. Obesity 23, 893–897 (2015).
Google Scholar
Kuk, J. L. et al. Visceral fat is an independent predictor of all-cause mortality in men. Obesity14, 336–341 (2006).
Google Scholar
Saad, R. K. et al. Abdominal visceral adipose tissue and all-cause mortality: a systematic review. Front. Endocrinol. 13, 922931 (2022).
Google Scholar
Muzumdar, R. et al. Visceral adipose tissue modulates mammalian longevity. Aging Cell 7, 438–440 (2008).
Google Scholar
Sierra Rojas, J. X. et al. Differential development of inflammation and insulin resistance in different adipose tissue depots along aging in Wistar rats: effects of caloric restriction. J. Gerontol. A Biol. Sci. Med. Sci. 71, 310–322 (2016).
Google Scholar
Masternak, M. M. et al. Metabolic effects of intra-abdominal fat in GHRKO mice. Aging Cell 11, 73–81 (2012).
Google Scholar
Menon, V. et al. The contribution of visceral fat to improved insulin signaling in Ames dwarf mice. Aging Cell 13, 497–506 (2014).
Google Scholar
Bennis, M. T. et al. The role of transplanted visceral fat from the long-lived growth hormone receptor knockout mice on insulin signaling. Geroscience 39, 51–59 (2017).
Google Scholar
Lane, M. A., Ingram, D. K. & Roth, G. S. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicol. Sci. 52, 41–48 (1999).
Google Scholar
Mattison, J. A. et al. Caloric restriction improves health and survival of rhesus monkeys. Nat. Commun. 8, 14063 (2017).
Google Scholar
Xia, J. et al. Associations between weight-adjusted-waist index and telomere length: results from NHANES: an observational study. Medicine 103, e37905 (2024).
Google Scholar
Xu, C., Song, Z., Wang, J. & Li, C. Association of visceral adiposity index with phenotypic age acceleration: insight from NHANES 1999–2010. J. Nutr. Health Aging 28, 100323 (2024).
Google Scholar
de Toro-Martín, J. et al. Body mass index is associated with epigenetic age acceleration in the visceral adipose tissue of subjects with severe obesity. Clin. Epigenetics 11, 172 (2019).
Google Scholar
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E. & Klein, S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 1010–1013 (2007).
Google Scholar
Yu, J. -Y., Choi, W. -J., Lee, H. -S. & Lee, J. -W. Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults. Medicine 98, e14740 (2019).
Google Scholar
Lynam-Lennon, N. et al. Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma. BMC Cancer 14, 907 (2014).
Google Scholar
Ngo, D. T. M. et al. Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity. Am. J. Physiol. Endocrinol. Metab. 316, E168–E177 (2019).
Google Scholar
Pafili, K. et al. Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease. J. Hepatol. 77, 1504–1514 (2022).
Google Scholar
Li, B. et al. Visceral fat obesity correlates with frailty in middle-aged and older adults. Diabetes Metab. Syndr. Obes. 15, 2877–2884 (2022).
Google Scholar
Schaum, N. et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature 583, 596–602 (2020).
Google Scholar
Carroll, J. F. et al. Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity 17, 1420–1427 (2009).
Google Scholar
Srinivasa, S. et al. Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV. AIDS 33, 229–236 (2019).
Google Scholar
Lemieux, I. et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler. Thromb. Vasc. Biol. 21, 961–967 (2001).
Google Scholar
Cartier, A. et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am. J. Clin. Nutr. 89, 1307–1314 (2009).
Google Scholar
Alvehus, M., Burén, J., Sjöström, M., Goedecke, J. & Olsson, T. The human visceral fat depot has a unique inflammatory profile. Obesity 18, 879–883 (2010).
Google Scholar
Lasselin, J. et al. Inflammation in the visceral adipose tissue of obese subjects: relationship with circulating inflammation and association with bariatric surgery outcomes. Brain. Behav. Immun. 40, e29 (2014).
Google Scholar
Li, X. et al. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct. Target. Ther. 8, 239 (2023).
Google Scholar
Rakotoarivelo, V. et al. Inflammatory cytokine profiles in visceral and subcutaneous adipose tissues of obese patients undergoing bariatric surgery reveal lack of correlation with obesity or diabetes. EBioMedicine 30, 237–247 (2018).
Google Scholar
Safarchi, A., Al-Qadami, G., Tran, C. D. & Conlon, M. Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges. Front. Microbiol. 16, 1559521 (2025).
Google Scholar
Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772 (2007).
Google Scholar
Asterholm, I. W. et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20, 103–118 (2014).
Google Scholar
Zhu, Q. et al. Suppressing adipocyte inflammation promotes insulin resistance in mice. Mol. Metab. 39, 101010 (2020).
Google Scholar
Yu, L. et al. IgG is an aging factor that drives adipose tissue fibrosis and metabolic decline. Cell Metab. 36, 793–807 (2024).
Google Scholar
Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).
Google Scholar
Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell 18, e12950 (2019).
Google Scholar
Alessio, N. et al. Obesity is associated with senescence of mesenchymal stromal cells derived from bone marrow, subcutaneous and visceral fat of young mice. Aging 12, 12609–12621 (2020).
Google Scholar
Sawaki, D. et al. Osteopontin promotes age-related adipose tissue remodeling through senescence-associated macrophage dysfunction. JCI Insight 8, e145811 (2023).
Google Scholar
Yamada, T., Kamiya, M., Higuchi, M. & Nakanishi, N. Fat depot-specific differences of macrophage infiltration and cellular senescence in obese bovine adipose tissues. J. Vet. Med. Sci. 80, 1495–1503 (2018).
Google Scholar
Kavanagh, K. et al. Biomarkers of senescence in non-human primate adipose depots relate to aging. Geroscience 43, 343–352 (2021).
Google Scholar
Escobar Marcillo, D. I. et al. The dual nature of DNA damage response in obesity and bariatric surgery-induced weight loss. Cell Death Dis. 15, 664 (2024).
Google Scholar
Behtaj, D. et al. Ex vivo anti-senescence activity of N-acetylcysteine in visceral adipose tissue of obese volunteers. Obes. Facts 17, 355–363 (2024).
Google Scholar
Chinnapaka, S., Malekzadeh, H., Tirmizi, Z. & Ejaz, A. Caloric restriction mitigates age-associated senescence characteristics in subcutaneous adipose tissue-derived stem cells. Aging 16, 7535–7552 (2024).
Google Scholar
Starr, M. E., Evers, B. M. & Saito, H. Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J. Gerontol. A. Biol. Sci. Med. Sci. 64A, 723–730 (2009).
Google Scholar
Espinosa De Ycaza, A. E. et al. Senescent cells in human adipose tissue: a cross-sectional study. Obesity 29, 1320–1327 (2021).
Google Scholar
Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994).
Google Scholar
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746–26749 (1995).
Google Scholar
Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295 (1996).
Google Scholar
Flier, J. S. & Ahima, R. S. Leptin physiology and pathophysiology: knowns and unknowns 30 years after its discovery. J. Clin. Invest. 134, e174595 (2024).
Google Scholar
Straub, L. G. & Scherer, P. E. Metabolic messengers: adiponectin. Nat. Metab. 1, 334–339 (2019).
Google Scholar
Tsai, J. -P. The association of serum leptin levels with metabolic diseases. Tzu Chi Med. J. 29, 192–196 (2017).
Google Scholar
Zhao, S. et al. Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab. 30, 706–719 (2019).
Google Scholar
Zhao, S. et al. Partial leptin deficiency confers resistance to diet-induced obesity in mice. Mol. Metab. 37, 100995 (2020).
Google Scholar
Zhao, S. et al. Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders. Sci. Transl. Med. 15, eade8460 (2023).
Google Scholar
Zhao, S. et al. Leptin reduction as a required component for weight loss. Diabetes 73, 197–210 (2023).
Google Scholar
Zhao, S., Kusminski, C. M., Elmquist, J. K. & Scherer, P. E. Leptin: less is more. Diabetes 69, 823–829 (2020).
Google Scholar
Zhao, S., Kusminski, C. M. & Scherer, P. E. Adiponectin, Leptin and cardiovascular disorders. Circ. Res. 128, 136–149 (2021).
Google Scholar
Pérez-Pérez, A., Sánchez-Jiménez, F., Vilariño-García, T. & Sánchez-Margalet, V. Role of leptin in inflammation and vice versa. Int. J. Mol. Sci. 21, 5887 (2020).
Google Scholar
Han, Y. et al. New advances of adiponectin in regulating obesity and related metabolic syndromes. J. Pharm. Anal. 14, 100913 (2024).
Google Scholar
Holland, W. L. et al. The pleiotropic actions of adiponectin are initiated via receptor-mediated activation of ceramidase activity. Nat. Med. 17, 55–63 (2011).
Google Scholar
Zhao, S. et al. The adiponectin-PPARγ axis in hepatic stellate cells regulates liver fibrosis. Cell Rep. 44, 115165 (2025).
Google Scholar
Côté, M. et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J. Clin. Endocrinol. Metab. 90, 1434–1439 (2005).
Google Scholar
Medina-Bravo, P. et al. Decrease in serum adiponectin levels associated with visceral fat accumulation independent of pubertal stage in children and adolescents. Arch. Med. Res. 42, 115–121 (2011).
Google Scholar
Reneau, J. et al. Effect of adiposity on tissue-specific adiponectin secretion. PLoS ONE 13, e0198889 (2018).
Google Scholar
Han, S. J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E. & Leonetti, D. L. Low plasma adiponectin concentrations predict increases in visceral adiposity and insulin resistance. J. Clin. Endocrinol. Metab. 102, 4626–4633 (2017).
Google Scholar
Li, N. et al. Adiponectin preserves metabolic fitness during aging. eLife 10, e65108 (2021).
Google Scholar
Ye, R. et al. Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration. eLife 3, e03851 (2014).
Google Scholar
Sasaki, T. et al. Status and physiological significance of circulating adiponectin in the very old and centenarians: an observational study. eLife 12, e86309 (2023).
Google Scholar
Pereira da Silva, A. et al. Body composition assessment and nutritional status evaluation in men and women Portuguese centenarians. J. Nutr. Health Aging 20, 256–266 (2016).
Google Scholar
He, K. et al. Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation. Immun. Ageing 20, 15 (2023).
Google Scholar
Guo, B. et al. MiRNA-132/212 encapsulated by adipose tissue-derived exosomes worsen atherosclerosis progression. Cardiovasc. Diabetol. 23, 331 (2024).
Google Scholar
Xie, Z. et al. Adipose-derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization. J. Am. Heart Assoc. 7, e007442 (2018).
Google Scholar
Wei, M. et al. Visceral adipose tissue derived exosomes exacerbate colitis severity via pro-inflammatory miRNAs in high fat diet fed mice. ACS Nano 14, 5099–5110 (2020).
Google Scholar
Tang, Y. et al. Exosomal miR-27b-3p secreted by visceral adipocytes contributes to endothelial inflammation and atherogenesis. Cell Rep. 42, 111948 (2023).
Google Scholar
Wang, J. et al. Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance. Cell Metab. 34, 1264–1279 (2022).
Google Scholar
Ferrante, S. C. et al. Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease. Pediatr. Res. 77, 447–454 (2015).
Google Scholar
Yang, Z., Wei, Z., Wu, X. & Yang, H. Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: determination of targets for the treatment of obesity and associated metabolic disorders. Mol. Med. Rep. 18, 3314–3324 (2018).
Google Scholar
Qu, Q. et al. Exosomes from human omental adipose-derived mesenchymal stem cells secreted into ascites promote peritoneal metastasis of epithelial ovarian cancer. Cells 11, 3392 (2022).
Google Scholar
Item, F. & Konrad, D. Visceral fat and metabolic inflammation: the portal theory revisited. Obes. Rev. 13, 30–39 (2012).
Google Scholar
Dhokte, S. & Czaja, K. Visceral adipose tissue: the hidden culprit for type 2 diabetes. Nutrients 16, 1015 (2024).
Google Scholar
Hoffstedt, J., Arner, P., Hellers, G. & Lönnqvist, F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J. Lipid Res. 38, 795–804 (1997).
Google Scholar
Arner, P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med. 27, 435–438 (1995).
Google Scholar
Sztalryd, C. & Kraemer, F. B. Differences in hormone-sensitive lipase expression in white adipose tissue from various anatomic locations of the rat. Metabolism 43, 241–247 (1994).
Google Scholar
Janssen, J. A. M. J. L. The causal role of ectopic fat deposition in the pathogenesis of metabolic syndrome. Int. J. Mol. Sci. 25, 13238 (2024).
Google Scholar
Tripathy, D. et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52, 2882–2887 (2003).
Google Scholar
Boden, G. Obesity and free fatty acids (FFA). Endocrinol. Metab. Clin. North Am. 37, 635–646 (2008).
Google Scholar
Bézaire, V. & Langin, D. Regulation of adipose tissue lipolysis revisited: symposium on ‘Frontiers in adipose tissue biology’. Proc. Nutr. Soc. 68, 350–360 (2009).
Google Scholar
Nomura, D. K. et al. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 49–61 (2010).
Google Scholar
Zhao, S. et al. α/β-Hydrolase domain-6-accessible monoacylglycerol controls glucose-stimulated insulin secretion. Cell Metab. 19, 993–1007 (2014).
Google Scholar
Zhao, S. et al. α/β-Hydrolase domain-6 and saturated long chain monoacylglycerol regulate insulin secretion promoted by both fuel and non-fuel stimuli. Mol. Metab. 4, 940–950 (2015).
Google Scholar
Zhao, S. et al. α/β-hydrolase domain 6 deletion induces adipose browning and prevents obesity and type 2 diabetes. Cell Rep. 14, 2872–2888 (2016).
Google Scholar
Poursharifi, P. et al. Adipose ABHD6 regulates tolerance to cold and thermogenic programs. JCI Insight 5, e140294 (2020).
Google Scholar
Cheng, D. et al. MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. Cell Metab. 34, 1732–1748 (2022).
Google Scholar
Poursharifi, P. et al. Suppression of adipocyte ABHD6 favors anti-inflammatory and adipogenic programs to preserve adipose tissue fitness in obesity. Mol. Metab. 101, 102241 (2025).
Google Scholar
Yore, M. M. et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 159, 318–332 (2014).
Google Scholar
Kellerer, T. et al. Fatty acid esters of hydroxy fatty acids (FAHFAs) are associated with diet, BMI, and age. Front. Nutr. 8, 691401 (2021).
Google Scholar
Held, N. M. et al. Aging selectively dampens oscillation of lipid abundance in white and brown adipose tissue. Sci. Rep. 11, 5932 (2021).
Google Scholar
Showalter, M. R. et al. The emerging and diverse roles of bis(monoacylglycero) phosphate lipids in cellular physiology and disease. Int. J. Mol. Sci. 21, 8067 (2020).
Google Scholar
Cai, X. et al. BCAA was more closely associated with visceral fat area than subcutaneous fat area in patients of type 2 diabetes mellitus: a cross-sectional study. BMC Endocr. Disord. 24, 236 (2024).
Google Scholar
Abdualkader, A. M., Karwi, Q. G., Lopaschuk, G. D. & Al Batran, R. The role of branched-chain amino acids and their downstream metabolites in mediating insulin resistance. J. Pharm. Pharm. Sci. 27, 13040 (2024).
Google Scholar
Han, H. -S. et al. Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement. Nat. Aging 3, 982–1000 (2023).
Google Scholar
Di Francesco, A. et al. Dietary restriction impacts health and lifespan of genetically diverse mice. Nature 634, 684–692 (2024).
Google Scholar
Masoro, E. J. Overview of caloric restriction and ageing. Mech. Ageing Dev. 126, 913–922 (2005).
Google Scholar
Liao, C. et al. Fat maintenance is a predictor of the murine lifespan response to dietary restriction. Aging Cell 10, 629–639 (2011).
Google Scholar
Vissers, D. et al. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS ONE 8, e56415 (2013).
Google Scholar
Gleeson, M. et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11, 607–615 (2011).
Google Scholar
Steensberg, A. et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529, 237–242 (2000).
Google Scholar
Gray, S. R. et al. The response of circulating levels of the interleukin-6/interleukin-6 receptor complex to exercise in young men. Cytokine 47, 98–102 (2009).
Google Scholar
Wedell-Neergaard, A. -S. et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized controlled trial. Cell Metab. 29, 844–855 (2019).
Google Scholar
Schafer, M. J. et al. Exercise prevents diet-induced cellular senescence in adipose tissue. Diabetes 65, 1606–1615 (2016).
Google Scholar
Kimura, M. et al. The effects of continuous and withdrawal voluntary wheel running exercise on the expression of senescence-related genes in the visceral adipose tissue of young mice. Int. J. Mol. Sci. 22, 264 (2021).
Google Scholar
Recchia, F. et al. Dose–response effects of exercise and caloric restriction on visceral adiposity in overweight and obese adults: a systematic review and meta-analysis of randomised controlled trials. Br. J. Sports Med. 57, 1035–1041 (2023).
Google Scholar
Merlotti, C., Ceriani, V., Morabito, A. & Pontiroli, A. E. Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis. Int. J. Obes. 41, 672–682 (2017).
Google Scholar
Rayner, J. J. et al. Disproportionate abdominal visceral fat mass reduction and complete reversal of cardiovascular remodelling accompany Roux-en-Y gastric bypass but not gastric banding – benefits beyond simply weight loss. J. Cardiovasc. Magn. Reson. 18, O135 (2016).
Google Scholar
Ghanem, O. M. et al. Continued diabetes remission despite weight recurrence: gastric bypass long-term metabolic benefit. J. Am. Coll. Surg. 238, 862–871 (2024).
Google Scholar
Adams, T. D., Mehta, T. S., Davidson, L. E. & Hunt, S. C. All-cause and cause-specific mortality associated with bariatric surgery: a review. Curr. Atheroscler. Rep. 17, 74 (2015).
Google Scholar
Liao, C., Liang, X., Zhang, X. & Li, Y. The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: a systematic review and meta-analysis. PLoS ONE 18, e0289616 (2023).
Google Scholar
Moiz, A. et al. Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation. Am. J. Med. 138, 934–940 (2025).
Google Scholar
Liu, F. et al. The effects of glucagon-like peptide-1 receptor agonists on adipose tissues in patients with type 2 diabetes: a meta-analysis of randomised controlled trials. PLoS ONE 17, e0270899 (2022).
Google Scholar
Zhao, L. et al. The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution. J Endocrinol. (2019).
Yao, H. et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ 384, e076410 (2024).
Google Scholar
Rivera, F. B. et al. Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: a meta-analysis and meta-regression. Diabetes Obes. Metab. 26, 2209–2228 (2024).
Google Scholar
Simental-Mendía, L. E., Sánchez-García, A., Linden-Torres, E. & Simental-Mendía, M. Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: a meta-analysis of randomized controlled trials. Diabetes Res. Clin. Pract. 177, 108899 (2021).
Google Scholar
Simental-Mendía, L. E., Sánchez-García, A., Linden-Torres, E. & Simental-Mendía, M. Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: a meta-analysis of randomized controlled trials. Br. J. Clin. Pharmacol. 87, 4140–4149 (2021).
Google Scholar
Sakamoto, K., Okahata, S., Mitsumatsu, T. & Shiba, T. Effect of GLP-1 receptor agonists on free fatty acids and implication for preventing atherosclerosis. Atherosclerosis 263, e161–e162 (2017).
Google Scholar
Mehdi, S. F. et al. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Front. Immunol. 14, 1148209 (2023).
Google Scholar
Cortes, T. M. et al. Effect of semaglutide on physical function, body composition, and biomarkers of aging in older adults with overweight and insulin resistance: protocol for an open-labeled randomized controlled trial. JMIR Res. Protoc. 13, e62667 (2024).
Google Scholar
Rodriguez, P. J. et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw. Open 8, e2457349 (2025).
Google Scholar
Berg, S., Stickle, H., Rose, S. J. & Nemec, E. C. Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis. Obes. Rev. 26, e13929 (2025).
Google Scholar
Jiang, N. et al. Repeated withdrawal of a GLPR agonist induces hyperleptinemia and deteriorates metabolic health in obese aging UM-HET3 mice. Aging Cell 24, e70210 (2025).
Google Scholar
Scarpace, P. J. et al. Rapamycin normalizes serum leptin by alleviating obesity and reducing leptin synthesis in aged rats. J. Gerontol. A. Biol. Sci. Med. Sci. 71, 891–899 (2016).
Google Scholar
Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).
Google Scholar
Kim, Y. -W. et al. Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance. Diabetes 55, 716–724 (2006).
Google Scholar
Otvos, L. et al. Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol. 11, 90 (2011).
Google Scholar
Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493–499 (2013).
Google Scholar
Balasubramanian, P. et al. Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice. eLife 11, e71282 (2022).
Google Scholar
Ng, R. C. -L. et al. Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer’s disease mouse model. Mol. Psychiatry 26, 5669–5689 (2021).
Google Scholar
Nicolas, S. et al. Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression. Transl. Psychiatry 8, 159 (2018).
Google Scholar
Tanabe, H. et al. Crystal structures of the human adiponectin receptors. Nature 520, 312–316 (2015).
Google Scholar
Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 20, 242–258 (2019).
Google Scholar
Wang, G. et al. Distinct adipose progenitor cells emerging with age drive active adipogenesis. Science 388, eadj0430 (2025).
Google Scholar
Maniyadath, B., Zhang, Q., Gupta, R. K. & Mandrup, S. Adipose tissue at single-cell resolution. Cell Metab. 35, 386–413 (2023).
Google Scholar
Ussher, J. R. et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453–2464 (2010).
Google Scholar
Holland, W. L. et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5, 167–179 (2007).
Google Scholar
Poisson, J. et al. Safe and orally bioavailable inhibitor of serine palmitoyltransferase improves age-related sarcopenia. ACS Pharmacol. Transl. Sci. 8, 203–215 (2025).
Google Scholar
Li, Y. et al. Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis. Sci. Rep. 12, 7273 (2022).
Google Scholar
Xia, Q. -S. et al. Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2α. Biomed. Pharmacother. 150, 112955 (2022).
Google Scholar
Zhao, H. et al. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes 67, 235–247 (2017).
Google Scholar
Bertholet, A. M. et al. Mitochondrial patch-clamp of beige adipocytes reveals UCP1-positive and UCP1-negative cells both exhibiting futile creatine cycling. Cell Metab. 25, 811–822 (2017).
Google Scholar
Yang, X. et al. Switching harmful visceral fat to beneficial energy combustion improves metabolic dysfunctions. JCI Insight 2, e89044 (2017).
Google Scholar
Queen, N. J. et al. Visceral adipose tissue-directed FGF21 gene therapy improves metabolic and immune health in BTBR mice. Mol. Ther. Methods Clin. Dev. 20, 409–422 (2021).
Google Scholar
Anderson, J. M. et al. Long-term effects of a fat-directed FGF21 gene therapy in aged female mice. Gene Ther. 31, 95–104 (2024).
Google Scholar
Gliniak, C. M. et al. FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression. Cell Metab. 37, 1547–1567 (2025).
Google Scholar
McFarlin, B. K., Tanner, E. A., Hill, D. W. & Vingren, J. L. Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk. Genes Nutr. 17, 15 (2022).
Google Scholar
Shen, M. -C., Zhao, X., Siegal, G. P., Desmond, R. & Hardy, R. W. Dietary stearic acid leads to a reduction of visceral adipose tissue in athymic nude mice. PLoS ONE 9, e104083 (2014).
Google Scholar
Iacobellis, G. & Bianco, A. C. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol. Metab. 22, 450–457 (2011).
Google Scholar
Wu, Z. et al. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G659–G670 (2018).
Google Scholar
Meza-Perez, S. & Randall, T. D. Immunological functions of the omentum. Trends Immunol. 38, 526–536 (2017).
Google Scholar
Cruz-Migoni, S. & Caamaño, J. Fat-associated lymphoid clusters in inflammation and immunity. Front. Immunol. 7, 612 (2016).
Google Scholar
Coelho, M., Oliveira, T. & Fernandes, R. Biochemistry of adipose tissue: an endocrine organ. Arch. Med. Sci. 9, 191–200 (2013).
Google Scholar
Pasarica, M. et al. Reduced adipose tissue oxygenation in human obesity. Diabetes 58, 718–725 (2009).
Google Scholar
O’Rourke, R. W. et al. Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia 54, 1480–1490 (2011).
Google Scholar
Elgazar-Carmon, V., Rudich, A., Hadad, N. & Levy, R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J. Lipid Res. 49, 1894–1903 (2008).
Google Scholar
Carey, A. et al. Age-associated accumulation of B cells promotes macrophage inflammation and inhibits lipolysis in adipose tissue during sepsis. Cell Rep. 43, 113967 (2024).
Google Scholar
Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914–920 (2009).
Google Scholar
Kiran, S., Kumar, V., Murphy, E. A., Enos, R. T. & Singh, U. P. High fat diet-induced CD8+ T cells in adipose tissue mediate macrophages to sustain low-grade chronic inflammation. Front. Immunol. 12, 680944 (2021).
Google Scholar
Caso, G. et al. Peripheral fat loss and decline in adipogenesis in older humans. Metabolism 62, 337–340 (2013).
Google Scholar
Karagiannides, I. et al. Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1772–R1780 (2001).
Google Scholar
Prado, C. M. et al. Methodological standards for body composition—an expert-endorsed guide for research and clinical applications: levels, models, and terminology. Am. J. Clin. Nutr. 122, 384–391 (2025).
Google Scholar
link